World Health Organization site
Skip Navigation Links
Advanced Search
List ByExpand List By
Search Tips
ICTRP websiteExpand ICTRP website
Contact us
                   71 records for 32 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
  Showrecords per page     

1 2 3 4
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
An open-label study to evaluate the safety and tolerability of 200-mcg Dose of IPP-201101 in Patients With SLE
Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
Heat therapy(agnikarma) in Tennis Elbow
Investigation of effect of clot preventing drugs such as Rivaroxaban, Vitamin K Antagonists and Aspirin on prevention of stroke in patients having Rheumatic Heart Disease along with irregularity of heart rhythm (Atrial Fibrillation).
Not recruitingYesNCT03125213
A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects
The study of an investigational drug, Cenicriviroc, for the treatment of liver fibrosis in patients with Nonalcoholic Steatohepatitis (NASH). 22/02/2017 
Not recruitingNoNCT03044899
African Surgical Outcomes Study (ASOS)
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2016-002950-19-BG A Phase II Study of M2951 in SLE 27/03/2017 
AuthorisedEUCTR2016-002950-19-DE A Phase II Study of M2951 in SLE 12/04/2017 
Hepatitis C Study with GT 1 2 and 3.
Not recruitingYesNCT02932267
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
1 2 3 4
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history